Understanding airway proteins in asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study examines a protein called TSLP that may play a role in asthma inflammation. By looking at different versions of TSLP in your airway samples, researchers hope to learn more about asthma and potentially guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with asthma.
- You do not have other lung diseases like COPD.
- You are not a current smoker and have not smoked more than 10 pack-years (e.g., one pack a day for 10 years).
- You do not have an active infection, cancer, or tuberculosis.
- You have not taken antibiotics in the last 4 weeks.
- You do not use home oxygen therapy for more than 15 hours a day.
- You are not being treated with biologic therapies (like Xolair, Nucala, Dupixent, or Tezspire).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two proteins, called Ezrin and Pip5k1α, in the smooth muscle of the airways of people with asthma. By comparing samples from people with and without asthma, researchers hope to understand how these proteins may be involved in asthma.
This trial looks at how certain proteins (Transgelin-2, Metallothionein-2, and Ezrin) are associated with asthma. It may help researchers better understand asthma biology and potentially guide future treatments.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
This study tests how the nose reacts to a substance that causes mild inflammation in people with asthma. It may help understand airway inflammation and asthma better.
This study looks at how certain immune cells (eosinophils) work in people with asthma. It compares people with mild to severe asthma, including those who have or haven't taken biologic treatments, against people without asthma. The goal is to better understand asthma and find new ways to treat it.
This study looks at how your genes affect your asthma medications. It tests if knowing your DNA can help predict which treatment works best for you and why.
Hear when a new Asthma Atopic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.